 
New Vision® Response to Xango's Patent LawsuitScottsdale, Arizona — August 3, 2004
New Vision (www.newvision.com), the leader in innovative liquid nutritional health products addressed the status of its lawsuit with Xango regarding New Vision's best-selling Essential Vitamins™ Plus Mangosteen. Xango previously sued New Vision claiming that New Vision's Essential Vitamins Plus Mangosteen infringes on their patent. In its response to this lawsuit, among its other claims, New Vision requested that the court issue a ruling that New Vision's current formulation of its Essential Vitamins Plus Mangosteen does not in any manner infringe on Xango's U.S. Patent No. 6,730,333. New Vision had previously engaged independent nationally-recognized patent counsel to review this matter. After an extensive review of the relevant issues, New Vision's patent counsel issued a legal opinion that New Vision's current formulation of its Essential Vitamins Plus Mangosteen does not infringe on Xango' s patent claims. B.K. Boreyko, chief executive officer for New Vision, stated "assuming
that Xango's patent is enforceable, a simple read of it indicates
that their patent only covers a product containing mangosteen,
pericarp and fruit or vegetable juices. New Vision's improved
formulation does not include fruit or vegetable juices and therefore
is not covered by the patent. Similarly, this is why you see so
many other mangosteen products in the market. Claims by Xango and
its distributors that New Vision's mangosteen product infringes
on Xango's patent may make good marketing copy, but that
is about it. We are extremely confident in our position."
|
|||